Compare Stocks: BTCY, ICCM, FEMY, and NXL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTCY Biotricity	$0.11 -13.5%	$0.12	$0.09 ▼ $0.75	$2.63M	1.13	53,834 shs	1,071 shs
FEMY Femasys	$2.98 +0.7%	$3.34	$2.02 ▼ $22.20	$24.79M	-2.08	2.09 million shs	294,388 shs
ICCM IceCure Medical	$2.27 -6.6%	$3.90	$2.12 ▼ $42.00	$8.33M	0.47	128,491 shs	655,234 shs
NXL Nexalin Technology	$0.32 -5.0%	$0.38	$0.31 ▼ $2.00	$7.32M	4	148,653 shs	253,281 shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTCY Biotricity	-13.54%	-1.58%	-1.63%	-21.40%	-78.79%
FEMY Femasys	+0.68%	+37.96%	-19.68%	-63.66%	-73.91%
ICCM IceCure Medical	-6.58%	-19.50%	-26.30%	-66.59%	-91.43%
NXL Nexalin Technology	-5.03%	-7.24%	-34.46%	-34.31%	-69.08%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTCY Biotricity	$0.11 -13.5%	$0.12	$0.09 ▼ $0.75	$2.63M	1.13	53,834 shs	1,071 shs
FEMY Femasys	$2.98 +0.7%	$3.34	$2.02 ▼ $22.20	$24.79M	-2.08	2.09 million shs	294,388 shs
ICCM IceCure Medical	$2.27 -6.6%	$3.90	$2.12 ▼ $42.00	$8.33M	0.47	128,491 shs	655,234 shs
NXL Nexalin Technology	$0.32 -5.0%	$0.38	$0.31 ▼ $2.00	$7.32M	4	148,653 shs	253,281 shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTCY Biotricity	-13.54%	-1.58%	-1.63%	-21.40%	-78.79%
FEMY Femasys	+0.68%	+37.96%	-19.68%	-63.66%	-73.91%
ICCM IceCure Medical	-6.58%	-19.50%	-26.30%	-66.59%	-91.43%
NXL Nexalin Technology	-5.03%	-7.24%	-34.46%	-34.31%	-69.08%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTCY Biotricity	0.00	N/A	N/A	N/A
FEMY Femasys	2.50	Moderate Buy	$50.00	1,577.85% Upside
ICCM IceCure Medical	2.20	Hold	$52.50	2,212.78% Upside
NXL Nexalin Technology	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest BTCY, ICCM, FEMY, and NXL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	NXL Nexalin Technology	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	FEMY Femasys	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00
8/17/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	FEMY Femasys	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00
8/14/2026	ICCM IceCure Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	ICCM IceCure Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/8/2026	NXL Nexalin Technology	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/3/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTCY Biotricity	$12.06M	0.19	N/A	N/A	($1.30) per share	-0.09
FEMY Femasys	$2.30M	10.85	N/A	N/A	$2.01 per share	1.48
ICCM IceCure Medical	$3.95M	1.97	N/A	N/A	$3.72 per share	0.61
NXL Nexalin Technology	$217.16K	32.01	N/A	N/A	$0.20 per share	1.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTCY Biotricity	-$14.09M	-$0.14	N/A	N/A	N/A	-80.42%	N/A	-188.47%	11/12/2026 (Estimated)
FEMY Femasys	-$18.63M	-$3.53	N/A	N/A	N/A	-534.36%	-225.97%	-74.68%	N/A
ICCM IceCure Medical	-$15.06M	-$8.52	N/A	N/A	N/A	-427.67%	-174.26%	-112.58%	N/A
NXL Nexalin Technology	-$8.22M	-$0.48	N/A	N/A	N/A	-4,141.94%	-278.24%	-218.42%	9/2/2026 (Estimated)

Latest BTCY, ICCM, FEMY, and NXL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/2/2026	Q2 2026	NXL Nexalin Technology	-$0.10	N/A	N/A	N/A	$0.09 million	N/A
8/14/2026	Q2 2026	FEMY Femasys	-$1.31	-$1.33	-$0.02	-$1.33	$0.73 million	$0.33 million
8/12/2026	Q2 2026	NXL Nexalin Technology	-$0.10	-$0.11	-$0.01	-$0.11	$0.09 million	$0.01 million
6/30/2026	Q2 2026	ICCM IceCure Medical	N/A	-$1.64	N/A	-$1.6350	N/A	$0.91 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
ICCM IceCure Medical	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTCY Biotricity	N/A	0.23	0.10
FEMY Femasys	0.89	2.14	0.55
ICCM IceCure Medical	N/A	2.88	2.44
NXL Nexalin Technology	N/A	1.25	1.10

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTCY Biotricity	3.89%
FEMY Femasys	65.27%
ICCM IceCure Medical	0.62%
NXL Nexalin Technology	0.65%

Insider Ownership

Company	Insider Ownership
BTCY Biotricity	1.60%
FEMY Femasys	7.75%
ICCM IceCure Medical	2.44%
NXL Nexalin Technology	16.94%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTCY Biotricity	40	20.24 million	22.08 million	No Data
FEMY Femasys	30	8.38 million	7.73 million	Not Optionable
ICCM IceCure Medical	60	3.43 million	3.34 million	Not Optionable
NXL Nexalin Technology	3	22.04 million	18.66 million	Not Optionable

BTCY, ICCM, FEMY, and NXL Headlines

Recent News About These Companies

Nexalin Technology Raises Liquidity via Short-Term Note

August 21, 2026 | tipranks.com

Nexalin Announces Capital Raise and Flexible Equity Facility

August 20, 2026 | tipranks.com

Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk

August 17, 2026 | tipranks.com

Nexalin Expands and Extends Houston Headquarters Lease Commitment

July 29, 2026 | tipranks.com

Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls

July 27, 2026 | tipranks.com

Nexalin Technology Corporate Event Calendar | NASDAQ:NXL

July 15, 2026 | benzinga.com

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s ...

June 23, 2026 | finance.yahoo.com

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company's Proprietary DIFS™ Platform

June 23, 2026 | globenewswire.com

Nexalin Overhauls Bylaws, Modernizes Corporate Governance Framework

June 17, 2026 | tipranks.com

Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across ...

June 16, 2026 | markets.businessinsider.com

Nexalin Technology, Inc. Announces Acceptance of Clinical Abstracts Showcasing DIFS™ Treatment Efficacy at 2026 NYC Neuromodulation Conference

June 16, 2026 | quiverquant.comQ

Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life

June 16, 2026 | globenewswire.com

Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across ...

June 10, 2026 | finance.yahoo.com

Nexalin Technology, Inc. Reports Successful Clinical Trial Results for Non-Invasive Neurostimulation Treatment of Anxiety and Depression

June 10, 2026 | quiverquant.comQ

Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.

June 10, 2026 | globenewswire.com

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

June 4, 2026 | globenewswire.com

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research ...

May 21, 2026 | markets.businessinsider.com

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury

May 21, 2026 | globenewswire.com

Nexalin Technology, Inc.: Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO Clarity and Nexalin NeuroCare Ahead of Planned FDA Pivotal Trial

May 20, 2026 | finanznachrichten.de

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial

May 19, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY, ICCM, FEMY, and NXL Company Descriptions

Biotricity NASDAQ:BTCY

$0.11 -0.02 (-13.54%)

As of 08/24/2026 11:28 AM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Femasys NASDAQ:FEMY

$2.98 +0.02 (+0.68%)

Closing price 08/24/2026 04:00 PM Eastern

Extended Trading

$2.94 -0.04 (-1.48%)

As of 04:00 AM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

IceCure Medical NASDAQ:ICCM

$2.27 -0.16 (-6.58%)

Closing price 08/24/2026 04:00 PM Eastern

Extended Trading

$2.28 +0.01 (+0.57%)

As of 04:00 AM Eastern

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Nexalin Technology NASDAQ:NXL

$0.32 -0.02 (-5.03%)

Closing price 08/24/2026 04:00 PM Eastern

Extended Trading

$0.32 +0.00 (+0.82%)

As of 08/24/2026 05:28 PM Eastern

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BTCY, ICCM, FEMY, and NXL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BTCY, ICCM, FEMY, and NXL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BTCY, ICCM, FEMY, and NXL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY, ICCM, FEMY, and NXL Company Descriptions

Biotricity NASDAQ:BTCY

Femasys NASDAQ:FEMY

IceCure Medical NASDAQ:ICCM

Nexalin Technology NASDAQ:NXL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BTCY, ICCM, FEMY, and NXL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BTCY, ICCM, FEMY, and NXL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BTCY, ICCM, FEMY, and NXL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY, ICCM, FEMY, and NXL Company Descriptions

Biotricity NASDAQ:BTCY

Femasys NASDAQ:FEMY

IceCure Medical NASDAQ:ICCM

Nexalin Technology NASDAQ:NXL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools